TimesSquare Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

TimesSquare Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500,920	Closed	-$74.8M	–	154
2024 Q3	$74.8M	Sell	500,920 -95,394	-16%	-$12.9M	1.12%	25
2024 Q2	$81.3M	Buy	596,314 +20,616	+4%	+$2.81M	1.28%	22
2024 Q1	$87M	Sell	575,698 -217,247	-27%	-$31M	1.27%	19
2023 Q4	$99.9M	Sell	792,945 -49,856	-6%	-$4.97M	1.47%	11
2023 Q3	$78.9M	Buy	842,801 +75,374	+10%	+$7.05M	1.23%	16
2023 Q2	$68.5M	Sell	767,427 -84,653	-10%	-$7.37M	0.98%	31
2023 Q1	$91.4M	Buy	852,080 +60,835	+8%	+$6.96M	1.34%	9
2022 Q4	$96.6M	Buy	791,245 +151,570	+24%	+$17.6M	1.38%	7
2022 Q3	$66.1M	Buy	639,675 +190,025	+42%	+$18M	0.92%	22
2022 Q2	$41.8M	Sell	449,650 -50,800	-10%	-$4.79M	0.58%	71
2022 Q1	$58.7M	Sell	500,450 -44,250	-8%	-$5.12M	0.66%	57
2021 Q4	$73.3M	Sell	544,700 -39,700	-7%	-$5.91M	0.65%	59
2021 Q3	$93.1M	Buy	584,400 +221,100	+61%	+$30.3M	0.81%	32
2021 Q2	$47.8M	Sell	363,300 -103,000	-22%	-$13.7M	0.39%	111
2021 Q1	$60.1M	Buy	466,300 +33,100	+8%	+$5.03M	0.51%	80
2020 Q4	$72.2M	Buy	433,200 +1,340	+0.3%	+$222K	0.59%	64
2020 Q3	$66.6M	Buy	431,860 +202,300	+88%	+$29.1M	0.62%	52
2020 Q2	$34M	Buy	+229,560	New	+$31.5M	0.32%	142

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

TimesSquare Capital Management's ASND Position: Q4 2024 in Review

TimesSquare Capital Management sold out of Ascendis Pharma A/S (ASND) in Q4 2024, closing a stake of 500,920 shares — an estimated $74.8M sold.

TimesSquare Capital Management first reported a position in ASND in Q2 2020 and held it in 18 quarters. The position peaked at $99.9M in Q4 2023. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.

TimesSquare Capital Management reported no remaining Ascendis Pharma A/S position as of Q4 2024 after selling out during the quarter.
TimesSquare Capital Management sold 500,920 Ascendis Pharma A/S shares in Q4 2024, an estimated $74.8M.
TimesSquare Capital Management first reported a position in Ascendis Pharma A/S in Q2 2020 and held it in 18 quarters.
TimesSquare Capital Management's Ascendis Pharma A/S position peaked at $99.9M in Q4 2023.
214 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2024.

Based on TimesSquare Capital Management's 13F filing for Q4 2024, filed 3 Feb 2025.